How to contact the center
Full member
HCP Center
The National Reference Center of Keratoconus (CRNK), includes the CHUs of Bordeaux and Toulouse. Its creation is part of the logic of the development of a reference center for "rare diseases" labeled by the Ministry of Health. Since the end of 2005, the ophthalmology services of the CHUs of Bordeaux and Toulouse have been designated as national reference centers for keratoconus because of their competence previously recognized in this field.
Within the framework of this mission, corneal specialists develop a communication and care network for keratoconus whose main objectives are:
The census and epidemiological study of patients with keratoconus.
The harmonization of diagnostic and therapeutic behavior.
Development and evaluation of new care options.
Public information about this rare disease.
Dissemination of scientific knowledge about the disease.
Picture : Don-vip
Within the framework of this mission, corneal specialists develop a communication and care network for keratoconus whose main objectives are:
The census and epidemiological study of patients with keratoconus.
The harmonization of diagnostic and therapeutic behavior.
Development and evaluation of new care options.
Public information about this rare disease.
Dissemination of scientific knowledge about the disease.
Picture : Don-vip
Contact
National Reference Center of Keratoconus (CRNK), CHU Toulouse, France
Service d'Ophtalmologie Pavillon Dieulafoy Place du Docteur BaylacTSA 40031
31000 Toulouse
France
Team
Pr Pierre FOURNIE
Representative
France
Anterior Segment Rare Eye Diseases (WG4), Registries & Epidemiology (TWG7), Research (TWG8)
Clinical trials
NCT04517903 - Completed
Validation Study on Eye Rubbing Questionnaire in Patients With or Suspected of Having a Keratoconus (KC) (QFK).
Interventional
NCT03584243 - Unknown
Transepithelial Corneal Collagen Crosslinking in Eyes With Progressive Keratoconus.
Interventional
NCT03464994 - Completed
Prevalence of Ophthalmological Abnormalities in Children and Adults Suffering From Hereditary Ichthyosis.
Interventional
NCT01756456 - Completed
Evaluation of safety and efficacy of r-hNGF in patients with stage 2 and 3 Neurotrophic Keratitis (REPARO).
Interventional
NCT03992417 - Active, Not recruiting
A Prospective Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis
Observational